Medicated Feed Additives Market Report 2025

The medicated feed additives market size has grown steadily in recent years. It will grow from $13.68 billion in 2024 to $14.33 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to prevalence of animal diseases, optimization of feed efficiency, government regulations for feed safety, globalization of feed additives market, preventive use in disease control programs.

The medicated feed additives market size is expected to see strong growth in the next few years. It will grow to $17.69 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to rise in aquaculture production, focus on gut health and digestive function, sustainable and ethical farming practices, research in antimicrobial peptides, global efforts in disease eradication. Major trends in the forecast period include extensive investments in R&D, product innovations, advancements in animal feed.

The anticipated increase in the consumption of poultry products is set to drive the growth of the medicated feed additives market in the future. Poultry products encompass any poultry carcass or products made wholly or partially from poultry carcasses, even those with a minimal poultry ingredient percentage. Medicated feed additives play a crucial role in preventing and treating coccidiosis, a parasitic intestinal tract disease in animals caused by coccidian protozoa, as well as necrotic enteritis, an enteric disease in poultry. The surge in poultry product consumption is expected to boost the demand for medicated feed additives to maintain poultry health. For instance, as of August 2022, the United States Department of Agriculture reported global poultry imports of 14.2 million metric tons in 2021, with an estimated 24% increase to reach 17.5 million metric tons by 2031. Consequently, the rise in poultry product consumption is a driving factor in the growth of the medicated feed additives market.

The increasing adoption of livestock farming is expected to drive the growth of the medicated feed additives market in the future. Livestock farming, also known as animal husbandry, involves breeding, raising, and managing domesticated animals for various purposes. Medicated feed additives are vital in this practice as they help prevent and control diseases, enhance animal health, improve growth rates and performance, optimize nutrition, reduce mortality rates, and boost feed utilization efficiency. For instance, in October 2024, Eurostat, a Luxembourg-based government agency, reported that in 2023, the European Union's livestock population included 133 million pigs, 74 million bovine animals, and 68 million sheep and goats. Furthermore, EU poultry meat production reached 13.3 million tonnes in 2023, an increase from 13 million tonnes in 2022. Therefore, the growing adoption of livestock farming is driving the growth of the medicated feed additives market.

Product innovation is a significant trend gaining traction in the medicated feed additives market. Key players are focusing on developing innovative products, including new active ingredients, alternative delivery systems, combination products, and precision medicine. For example, in June 2023, Evonik Industries, a Germany-based chemical manufacturer, launched an updated version of its Biolys product for animal feed. This enhanced formulation features a higher concentration of L-lysine, an essential amino acid vital for optimal nutrition in animals, particularly pigs and poultry. The new Biolys formulation serves as a more efficient source of L-lysine, promoting better growth and feed efficiency in livestock. Evonik's advancements in Biolys technology highlight its commitment to sustainability, efficiency, and improved nutritional benefits in animal feed.

Major companies in the medicated feed additives market are prioritizing advanced next-gen solutions to drive market revenues. Advanced medicated feed additives typically offer a higher concentration of L-lysine for animal feed. In June 2023, Evonik Industries AG, a Germany-based chemicals company, launched biolys, a product derived through a fermentation process that produces additional nutrients and energy beneficial to livestock, such as pigs and poultry. The fermentation process transforms corn-based sugar dextrose into L-lysine. This innovative solution allows clients to more efficiently provide essential amino acid L-lysine to their animals, achieving the same results with fewer products.

In April 2024, Phibro Animal Health Corp., a US-based pharmaceutical manufacturing company, acquired Zoetis Inc. for $350 million. This acquisition supports Zoetis' strategic capital reallocation, enabling the company to concentrate on its core areas, including vaccines and biologics for animal health. Zoetis Inc. specializes in animal health products, providing a wide range of solutions for both companion animals and livestock, including medicines, vaccines, diagnostic products, and medicated feed additives.

Major companies operating in the medicated feed additives market include Archer-Daniels-Midland Company, Cargill Incorporated, CHS Inc., Zoetis Services LLC, Purina Animal Nutrition LLC, China National Bluestar (Group) Co. Ltd., Alltech, Zagro Corporation, Hi-Pro Feeds, Biostadt Limited, BASF SE, Evonik Industries AG, Novozymes A/S, Nutreco NV, Phibro Animal Health Corporation, Chr. Hansen A/S, Red Nucleus LLC, MITSUI & Co. Ltd., FEED ONE Co. Ltd., NOSAN CORPORATION, Kemin Industries Inc., Provimi Holding BV, Lallemand Inc., Novus International Inc., DSM Nutritional Products AG, DuPont de Nemours Inc., Trouw Nutrition International B.V., Koninklijke DSM N.V., Solvay SA, Ajinomoto Co. Inc.

Asia-Pacific was the largest region in the medicated feed additives market in 2024. The regions covered in the medicated feed additives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medicated feed additives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medicated feed additives encompass feeds that contain one or more drugs intended to enhance the health and productivity of animals. Animals receive medicated feed additives for various purposes, such as nutrition, medication, management of worms, bacterial diseases, and coccidiosis, as well as for preventing mortality.

The primary types of medicated feed additives include antibiotics, vitamins, antioxidants, amino acids, prebiotics, probiotics, enzymes, and others. Antibiotics are medications used both for the prevention and treatment of bacterial infections. These additives are administered to various animal types, including ruminants, swine, poultry, aquaculture, and others, using a variety of mixture types such as supplements, concentrates, premixes, and base mixes.

The medicated feed additives market research report is one of a series of new reports that provides medicated feed additives market statistics, including medicated feed additives industry global market size, regional shares, competitors with a medicated feed additives market share, detailed medicated feed additives market segments, market trends and opportunities, and any further data you may need to thrive in the medicated feed additives industry. This medicated feed additives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medicated feed additives market consists of sales of lonophores, buffers, yeast cultures, and bloat-prevention aids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.